Clinical Trials Logo

Optical Coherence Tomography clinical trials

View clinical trials related to Optical Coherence Tomography.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05041777 Active, not recruiting - Clinical trials for Basal Cell Carcinoma

Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma

OCT-BCC
Start date: February 15, 2017
Phase:
Study type: Observational

Rationale: To date, the diagnosis and subtyping of basal cell carcinoma (BCC) is verified with histopathology which requires a biopsy. Because this technique is invasive, new non-invasive strategies have been developed, including Optical Coherence Tomography (OCT). This innovative technique enables microscopically detailed examination of lesions, which is useful for diagnosing and identification of various subtypes of BCC. The diagnostic value of the VIVOSIGHT OCT in daily clinical practice, has not been established to date.

NCT ID: NCT03848078 Active, not recruiting - Clinical trials for Basal Cell Carcinoma

(Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)

ROCTI
Start date: February 26, 2019
Phase: N/A
Study type: Interventional

A multi-centre randomized non-inferiority trial investigating the (cost-)effectiveness of Optical Coherence Tomography (OCT) versus regular punch biopsy in the diagnosis and subtyping of Basal Cell Carcinoma (BCC).